Alnylam Pharmaceuticals (ALNY) Prepaid Assets (2009 - 2026)

Alnylam Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $242.1 million for Q1 2026.

• Quarterly Prepaid Assets rose 58.84% year-over-year to $242.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $242.1 million (up 58.84% YoY) and the FY2025 annual result came in at $281.9 million, up 141.01% from the prior year.
• Prepaid Assets was $242.1 million for Q1 2026 at Alnylam Pharmaceuticals, down from $281.9 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $281.9 million in Q4 2025 and bottomed at $115.1 million in Q1 2022.
• A 5-year average of $157.8 million and a median of $145.5 million in 2023 frame the typical range for Prepaid Assets.
• Peak annual rise in Prepaid Assets reached 141.01% in 2025, while the deepest fall reached 24.53% in 2025.
• Alnylam Pharmaceuticals' Prepaid Assets stood at $132.9 million in 2022, then decreased by 4.92% to $126.4 million in 2023, then dropped by 7.45% to $117.0 million in 2024, then jumped by 141.01% to $281.9 million in 2025, then slipped by 14.11% to $242.1 million in 2026.
• Business Quant data shows ALNY's Prepaid Assets at $242.1 million in Q1 2026, $281.9 million in Q4 2025, and $188.0 million in Q3 2025.